Fundraising FoxSonendo
OTC: SONXLaguna Hills, US · Delaware corporation · 14 known investors
Find your way into Sonendo
Each arrow is one introduction. Sign up to fill in the first one.
245 people can intro you to John
Ask Melanie Hess to introduce you to John McGaugh
You →Melanie · together at American Medical Systems →John
Sign up to find every way you can get introduced to Sonendo
- Your email: who you already know at Sonendo, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sonendo team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sonendo is a medical technology company that develops and manufactures the GentleWave System, a technology platform for treating tooth decay by cleaning and disinfecting the interior spaces of teeth without removing tooth structure. It focuses on dental care and saving teeth from decay.
Founders & leadership
JM
John McGaughExecutiveJohn McGaugh is an Executive Officer at Sonendo with background in global manufacturing operations and supply chain management across the medical device, semiconductor, and optoelectronics industries. He has experience in process optimization, offshore operations transfer, and leading cross-functional teams.
JB
John BostjancicExecutive
HN
Hugh NeuharthExecutive
RT
Roy T. ChenChief Talent Officer
Board
OB
VB
Vince BurgessBoard director
PM
MZ
Michael ZhaoBoard director
FY
Fan YuBoard director
EA
Erik AmbleBoard director
Investors · 14
Essex Woodlands Healthcare Partnerslisted by Essex Woodlands Healthcare PartnersNew York · $20M – $80Mvia Brooks Andrews · led
How we know: Essex Woodlands Healthcare Partners's portfolio page · Not right? Tell us
Fjord VenturesreportedLaguna Hills
How we know: funding news · prnewswire.com · Not right? Tell us
General AtlanticreportedNew York · $10M – $1Bvia Alex Crisses · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Meritech Capital PartnersreportedPalo Alto · $5M – $40M
How we know: a partner's Signal profile · funding news · Not right? Tell us
Neomed Managementreported
How we know: prnewswire.com · Not right? Tell us
OrbiMedreportedNew York · $1M – $75M
How we know: funding news · prnewswire.com · Not right? Tell us
Pura Vida InvestmentsreportedNew York
How we know: ocbj.com · Not right? Tell us
Also in the syndicate · 6
ArrowMark PartnersBlue Water Life Science AdvisorsDriehaus Capital ManagementFirst Light Asset ManagementJMR CapitalThemes Investment Partners
Funding
SEC filings, press & company announcements$207.9M disclosed across 9 of 11 rounds · 2013–2025
- Undisclosed amountprivate placementOct 2022
ArrowMark Partners, Blue Water Life Science Advisors, Driehaus Capital Management, First Light Asset Management, JMR Capital, Pura Vida Investments
Source ↗
▶$5MraisedMay 2025 · 15 investors · Other Health CareRule 506(b)
▶$5MraisedMay 2025 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carolyn BeaverDirector
- Raj PudipeddiDirector
- Bjarne BergheimExecutive Officer, Director
- John McGaughExecutive Officer
- Anthony P. Bihl IIIDirector
- John BostjancicExecutive Officer
- Olav BergheimDirector
- Offering amount
- $15M
- Amount sold
- $5M
- Sales commissions
- $234.5K
- Placement agents
- Arcadia Securities, LLC
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$84.7MraisedDec 2019 · 19 investors · Other Health CareRule 506(b)
▶$84.7MraisedDec 2019 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul MaderaDirector
- Thomas R. EngelsDirector
- Daniel EvenDirector
- Vince BurgessDirector
- Michael WattsExecutive Officer
- Bjarne BergheimExecutive Officer, Director
- Olav B. BergheimExecutive Officer, Director
- Alex CrissesDirector
- Cory EavesDirector
- Brooks AndrewsDirector
- Offering amount
- $85.2M
- Amount sold
- $84.7M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedJul 2019 · 6 investors · Other Health CareRule 506(b)
▶$17MraisedJul 2019 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Olav B. BergheimExecutive Officer, Director
- Bjarne BergheimExecutive Officer, Director
- Michael WattsExecutive Officer
- Vince BurgessDirector
- Daniel EvenDirector
- Thomas R. EngelsDirector
- Paul MaderaDirector
- David CaluoriDirector
- Offering amount
- $17M
- Amount sold
- $17M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedNov 2018 · 10 investors · Other Health CareRule 506(b)
▶$25MraisedNov 2018 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Vince BurgessDirector
- David CaluoriDirector
- Daniel EvenDirector
- Thomas R. EngelsDirector
- Bjarne BergheimExecutive Officer, Director
- Paul MaderaDirector
- Michael WattsExecutive Officer
- Olav B. BergheimExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$850KraisedMay 2017 · 5 investors · Other Health CareRule 506(b)
▶$850KraisedMay 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bjarne BergheimExecutive Officer, Director
- Michael ZhaoDirector
- Vince BurgessDirector
- Thomas R. EngelsDirector
- Daniel EvenDirector
- Olav B. BergheimDirector
- Fan YuDirector
- Paul MaderaDirector
- John GlennExecutive Officer
- Erik AmbleDirector
- Offering amount
- $850K
- Amount sold
- $850K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJan 2017 · 1 investors · Other Health CareRule 506(b)
▶$4MraisedJan 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Vince BurgessDirector
- Michael ZhaoDirector
- Bjarne BergheimExecutive Officer, Director
- Paul MaderaDirector
- Fan YuDirector
- Erik AmbleDirector
- Daniel EvenDirector
- Olav B. BergheimDirector
- John GlennExecutive Officer
- Thomas R. EngelsDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$33.3MraisedMay 2016 · 12 investors · Other Health CareRule 506(b)
▶$33.3MraisedMay 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Hugh NeuharthExecutive Officer
- Olav B. BergheimDirector
- Vince BurgessDirector
- Bjarne BergheimExecutive Officer, Director
- Daniel EvenDirector
- Thomas R. EngelsDirector
- Paul MaderaDirector
- Michael ZhaoDirector
- Fan YuDirector
- Erik AmbleDirector
- Offering amount
- $45M
- Amount sold
- $33.3M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35MraisedSep 2014 · 8 investors · Other Health CareRule 506(b)
▶$35MraisedSep 2014 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott HuennekensDirector
- Paul MaderaDirector
- Daniel EvenDirector
- Fan YuDirector
- Vince BurgessDirector
- Bjarne BergheimExecutive Officer, Director
- Erik AmbleDirector
- Olav B. BergheimExecutive Officer, Director
- Thomas R. EngelsDirector
- Hugh NeuharthExecutive Officer
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Sonendo do?
- Sonendo is a medical technology company that develops and manufactures the GentleWave System, a technology platform for treating tooth decay by cleaning and disinfecting the interior spaces of teeth without removing tooth structure. It focuses on dental care and saving teeth from decay.
- Who founded Sonendo?
- Sonendo was founded by Bjarne Bergheim.
- Who are Sonendo's investors?
- Sonendo's investors include Essex Woodlands Healthcare Partners, Fjord Ventures, General Atlantic, Meritech Capital Partners, Neomed Management, OrbiMed, Pura Vida Investments, Welsh, Carson, Anderson & Stowe.
- How much funding has Sonendo raised?
- Sonendo has disclosed $207.9M raised across 9 of its 11 known rounds.
- Where is Sonendo headquartered?
- Sonendo is headquartered in Laguna Hills, US.